📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Kolltan

1.1 - Company Overview

Kolltan Logo

Kolltan

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel monoclonal antibody oncology therapeutics targeting receptor tyrosine kinases (RTKs); develops next-generation mAb drugs based on seminal discoveries from Dr. Joseph Schlessinger's Yale Pharmacology lab; founded in 2007 as a private company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Kolltan

EsoBiotec Logo

EsoBiotec

HQ: Belgium Website
  • Description: Provider of biotechnology solutions focused on the discovery of novel cancer therapies, aiming to enable the human body to fight cancer through in vivo cell engineering.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EsoBiotec company profile →
Gloucester Pharma Logo

Gloucester Pharma

HQ: United States Website
  • Description: Provider of biopharmaceutical development, acquiring clinical-stage oncology drug candidates and advancing them through regulatory approval and commercialization; owned by Celgene. Its first compound, romidepsin, is a late-stage oncology drug candidate.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gloucester Pharma company profile →
Lymphatica Medtech Logo

Lymphatica Medtech

HQ: Switzerland Website
  • Description: Provider of medical device development, creating a minimally invasive solution for chronic lymphedema.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lymphatica Medtech company profile →
Good Therapeutics Logo

Good Therapeutics

HQ: United States Website
  • Description: Provider of self-regulating, context-dependent protein therapeutics that sense biomarkers and activate in the tumor microenvironment. Portfolio includes ATP-IFNα, ATP-IL12, PD1-IL12, LAG3-IL2, LRRC15-IFNα, and LRRC15-antiTGFβR2, designed to drive anti-tumor immunity, deliver IL-12 while blocking PD-1/PD-L1 signaling, target cancer-associated fibroblasts, and minimize systemic toxicity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Good Therapeutics company profile →
Perspective Therapeutics Logo

Perspective Therapeutics

HQ: United States Website
  • Description: Provider of radiopharmaceutical cancer theranostics and targeted alpha-particle radiotherapy, including Pb-203 diagnostics and Pb-212 treatment via targeting peptides. Offers clinical programs VMT-α-NET for neuroendocrine tumors and VMT01 for metastatic melanoma, and a proprietary Pb-212 isotope generator to secure key isotopes for clinical trials and commercial operations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Perspective Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Kolltan

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Kolltan

2.2 - Growth funds investing in similar companies to Kolltan

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Kolltan

4.2 - Public trading comparable groups for Kolltan

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Kolltan

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Kolltan

What does Kolltan do?

Kolltan is a provider of novel monoclonal antibody oncology therapeutics targeting receptor tyrosine kinases (RTKs); develops next-generation mAb drugs based on seminal discoveries from Dr. Joseph Schlessinger's Yale Pharmacology lab; founded in 2007 as a private company.

Who are Kolltan's competitors?

Kolltan's competitors and similar companies include EsoBiotec, Gloucester Pharma, Lymphatica Medtech, Good Therapeutics, and Perspective Therapeutics.

Where is Kolltan headquartered?

Kolltan is headquartered in United States.

How many employees does Kolltan have?

Kolltan has 1,000 employees 🔒.

When was Kolltan founded?

Kolltan was founded in 2010 🔒.

What sector and industry vertical is Kolltan in?

Kolltan is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Kolltan

Who are the top strategic acquirers in Kolltan's sector and industry

Top strategic M&A buyers and acquirers in Kolltan's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Kolltan?

Top strategic M&A buyers groups and sectors for Kolltan include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Kolltan's sector and industry vertical

Which are the top PE firms investing in Kolltan's sector and industry vertical?

Top PE firms investing in Kolltan's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Kolltan's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Kolltan's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Kolltan's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Kolltan include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Kolltan's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Kolltan?

The key public trading comparables and valuation benchmarks for Kolltan include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Kolltan for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Kolltan with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Kolltan's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Kolltan with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Kolltan's' sector and industry vertical?

Access recent funding rounds and capital raises in Kolltan's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Kolltan